相关实验视频
Updated: Jan 8, 2026
12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
10.8K
由里瓦洛克萨班诱导的儿科牛性皮:一种罕见的病例报告,具有潜在的遗传性高凝血能力
Yen Hoang Phan1, Phi Duong Nguyen1, Khanh Ngoc Minh Nguyen1
1City Children's Hospital, Ho Chi Minh City, Viet Nam.
概括
作为XA因子抑制剂的里瓦罗克萨班在儿童中很少引起牛性皮炎 (BP). 这份病例报告详细介绍了一个8岁的男孩在里瓦洛克萨班治疗后患有高血压,强调及时诊断和管理.
科学领域:
- 儿科皮肤病学 儿科皮肤病学
- 自免疫性泡性疾病 自免疫性泡性疾病
- 药物监督 药物监督 药物监督
背景情况:
- 球状皮炎 (BP) 是一种罕见的自身免疫性水泡性疾病,主要影响老年人.
- 儿科高血压病例不常见,药物诱导的触发因素很少被报告.
- 利瓦罗克萨班是一种直接的XA因子抑制剂,其与过敏反应 (如高血压),高血压等过敏反应的相关记录有限.
研究的目的:
- 报告一个罕见的里瓦罗克萨班诱导的小儿病人的型尾虫病例.
- 为了突出利瓦罗克萨班可能触发儿童血压作为药物不良反应的潜力.
- 强调在儿科群体中识别和管理药物诱导的BP的重要性.
主要方法:
- 一个8岁的男孩的病例介绍,他患有状皮虫.
- 对患者的药物 anamnesis 的审查,包括 3 个月的里瓦洛克萨班治疗.
- 通过组织病理学检查和直接免疫光研究来确认诊断.
主要成果:
- 患者在里瓦洛克萨班治疗后发展出广泛的状皮虫病.
- 组织病理学和免疫光学证实了型皮虫的诊断.
- 立即停止利瓦罗克萨班治疗并开始全身性皮质类固醇治疗,导致临床情况迅速改善.
结论:
- 利瓦罗克萨班应该被认为是小儿病患者型皮虫的潜在触发因素.
- 这一案例凸显了对儿童里瓦罗克萨班诱导的血压增加临床意识的必要性.
- 及时诊断和管理,包括药物戒断和皮质类固醇治疗,对于有利的结果至关重要.
相关概念视频
01:29Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.0K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.0K
01:24Disorders of Hemostasis
1.9K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.9K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
270
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
270
01:35Pedigree Analysis
88.7K
Overview
88.7K